Can I Take Vitamin B6 with Enclomiphene Citrate?

What Is Enclomiphene Citrate and Why Do Men Take It?

Enclomiphene citrate is the trans-isomer of clomiphene citrate. It acts as a selective estrogen receptor modulator (SERM) at the hypothalamus and pituitary, blocking estrogen negative feedback and raising endogenous luteinizing hormone (LH) and follicle-stimulating hormone (FSH). The result is increased intratesticular and serum testosterone without suppressing spermatogenesis, which is the key clinical advantage over exogenous testosterone replacement therapy.

Regulatory Status and Approved Indications

The FDA has not approved enclomiphene as a standalone drug for secondary hypogonadism. Androxal, a proprietary enclomiphene citrate formulation, completed Phase III trials but did not receive final approval. Prescribers use enclomiphene off-label through compounding pharmacies. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism notes that SERMs can raise testosterone in men with secondary hypogonadism, though the guideline stops short of a formal enclomiphene-specific recommendation given limited long-term safety data. [1]

How Enclomiphene Is Metabolized

Clomiphene isomers are metabolized primarily by CYP3A4 and CYP2D6 in the liver, with secondary involvement of CYP3A5. [2] Enclomiphene has a shorter half-life (roughly 10 hours) than the cis-isomer zuclomiphene (half-life greater than 30 days). This shorter half-life matters for supplement timing discussions: enclomiphene clears relatively quickly, so any potential metabolic interaction with co-administered supplements is a shorter window of concern.

What Is Vitamin B6 and How Does It Work in the Body?

Vitamin B6 is a water-soluble B-vitamin that exists in six natural forms, with pyridoxal-5-phosphate (PLP) being the biologically active coenzyme form. PLP participates in over 100 enzymatic reactions, including amino acid metabolism, neurotransmitter synthesis (dopamine, serotonin, GABA), and steroid hormone receptor modulation. [3]

Dietary vs. Supplemental Doses

The NIH Office of Dietary Supplements sets the recommended dietary allowance (RDA) for adult men at 1.3 to 1.7 mg/day, rising to 1.7 mg/day after age 50. [4] Most multivitamins contain 2 to 10 mg. Standalone B6 supplements range from 25 mg to 500 mg per tablet. The tolerable upper intake level (UL) established by the Institute of Medicine is 100 mg/day for adults. Doses above that threshold are associated with progressive peripheral sensory neuropathy.

B6 and Prolactin: A Potential Additive Mechanism

Pyridoxal-5-phosphate is a cofactor in dopamine synthesis. Higher dopamine tone suppresses prolactin release from the pituitary. Several small studies suggest that supplemental B6 at doses of 200 to 300 mg/day can modestly lower serum prolactin. [5] Enclomiphene raises LH, which in turn raises testosterone and may indirectly affect the hypothalamic-pituitary axis. The combination of a prolactin-lowering effect from B6 and LH stimulation from enclomiphene is not documented as harmful, but the additive hormonal signaling means baseline prolactin measurement before starting either agent is reasonable clinical practice.

Does Vitamin B6 Interact Pharmacokinetically with Enclomiphene Citrate?

No published pharmacokinetic study has examined direct B6-enclomiphene interaction. Based on known metabolic pathways, a clinically meaningful pharmacokinetic interaction is unlikely at standard supplemental doses.

CYP Enzyme Considerations

Enclomiphene is a CYP3A4 substrate. Strong CYP3A4 inhibitors (ketoconazole, grapefruit juice at high volumes, ritonavir) raise enclomiphene plasma exposure and could amplify side effects. Pyridoxine and pyridoxal-5-phosphate are not CYP3A4 inhibitors or inducers at physiological or low supplemental concentrations. [6] A 2020 review in Drug Metabolism and Disposition confirmed that B-vitamins as a class do not meaningfully alter CYP3A4 activity in human hepatocyte models. [6] So enclomiphene blood levels are not expected to change when B6 is added at typical supplement doses.

P-glycoprotein and Transport Protein Overlap

Clomiphene isomers show some affinity for P-glycoprotein efflux transport. Vitamin B6 at standard doses does not significantly inhibit P-glycoprotein. No transporter-mediated interaction is expected between these two agents. [7]

Protein Binding

Both enclomiphene and PLP bind to plasma proteins (albumin and sex hormone-binding globulin for enclomiphene; albumin for PLP). Competitive displacement is theoretically possible but requires molar concentrations far above those achieved with standard dosing. At 25 mg/day enclomiphene and 100 mg/day B6, displacement is not a clinical concern.

What Are the Real Risks of Combining High-Dose B6 with Enclomiphene?

The main risk is not an interaction between the two compounds. It is the independent toxicity of high-dose vitamin B6, which can mimic or mask a neurological side effect evaluation during enclomiphene treatment.

Peripheral Neuropathy from High-Dose B6

Sustained intake above 200 mg/day of pyridoxine (not PLP) is linked to sensory peripheral neuropathy. A 1983 case series by Schaumburg et al. In the New England Journal of Medicine first documented this dose-dependent neurotoxicity in patients taking 2,000 to 6,000 mg/day. [8] Subsequent reports confirmed neuropathy at lower doses. A 2023 systematic review in the European Journal of Nutrition found case reports of neuropathy at chronic doses as low as 50 to 100 mg/day in sensitive individuals, though most cases occurred above 200 mg/day. [9]

Why This Matters During Enclomiphene Treatment

Enclomiphene, like all SERMs, can cause visual disturbances in a small percentage of users. Those visual changes and any co-occurring sensory complaints (tingling, numbness, balance issues) require careful neurological baseline evaluation. If a patient is simultaneously taking high-dose B6 and develops sensory symptoms, attributing the cause becomes difficult. Keeping B6 below 100 mg/day removes that diagnostic ambiguity.

No Direct Hormonal Toxicity from the Combination

Enclomiphene does not depend on B6 for its mechanism. SERM activity at estrogen receptors is not modulated by pyridoxal-5-phosphate. The SERM-driven LH surge is a receptor-mediated event independent of B-vitamin cofactor availability. [1] So there is no additive endocrine toxicity risk from combining therapeutic enclomiphene doses with standard B6 supplementation.

Pharmacodynamic Considerations: Could B6 Support or Undermine Enclomiphene's Goals?

The question of whether B6 is synergistic or neutral with enclomiphene requires examining the downstream hormonal goals of treatment.

Testosterone Synthesis Pathway

Testosterone biosynthesis in Leydig cells requires LH stimulation (provided by enclomiphene's mechanism) and intact steroidogenic enzymes. Several steps in androgen biosynthesis rely on PLP-dependent transamination reactions. [3] Severe B6 deficiency could theoretically impair steroidogenesis, but frank deficiency is rare in men eating a mixed diet. Supplemental B6 does not appear to accelerate testosterone synthesis beyond what LH stimulation already drives.

Estradiol and SHBG

Enclomiphene raises testosterone, which aromatizes peripherally to estradiol. Some practitioners worry about rising estradiol during SERM therapy. B6 does not meaningfully alter aromatase activity or sex hormone-binding globulin (SHBG) levels at supplemental doses. A 2005 study in the Journal of Steroid Biochemistry and Molecular Biology found no significant change in serum SHBG in men supplementing 100 mg/day pyridoxine over 8 weeks. [10]

Mood and Neurotransmitter Support

Men with secondary hypogonadism frequently report mood disturbances. B6 is a cofactor in serotonin and dopamine synthesis. Anecdotally, men on enclomiphene therapy sometimes add B6 to address mood symptoms. This rationale is not supported by controlled clinical evidence, but it explains why the combination is common in practice. At doses below 100 mg/day, adding B6 for this purpose carries minimal risk.

Dose Guidance: How Much B6 Is Safe Alongside Enclomiphene?

Dose thresholds matter more than the presence or absence of B6.

Tier 1: Dietary and Multivitamin Levels (up to 10 mg/day)

No concern. RDA-level B6 from food or a standard multivitamin (typically 2 to 10 mg) has no interaction with enclomiphene and poses no neuropathy risk. [4]

Tier 2: Low Supplemental Doses (10 to 100 mg/day)

Acceptable for most patients. This range covers common standalone B6 supplements and B-complex formulas. The NIH UL of 100 mg/day is the ceiling for this tier. [4] No pharmacokinetic interaction with enclomiphene is expected.

Tier 3: High Supplemental Doses (100 to 200 mg/day)

Use caution. Exceeds the NIH UL. Some individuals tolerate this range without neuropathy, but the risk begins to rise. Discuss with the prescribing physician before maintaining this dose alongside enclomiphene.

Tier 4: Very High Doses (above 200 mg/day)

Avoid without direct medical supervision. Peripheral neuropathy risk becomes clinically relevant. Cases of sensory neuropathy have been documented at this range, with symptom onset sometimes taking weeks to months. [8] [9] There is no established clinical benefit from doses this high in the context of enclomiphene therapy.

Monitoring Recommendations While Taking Both

Baseline labs before starting enclomiphene should include total testosterone, LH, FSH, estradiol, prolactin, and a comprehensive metabolic panel. [1] If B6 supplementation above 50 mg/day is continued, a baseline neurological screen documenting sensory function is reasonable, particularly in men over 50 or with diabetes.

Lab and Symptom Checkpoints

Follow-up testing at 6 to 8 weeks on enclomiphene typically captures the LH and testosterone response. At that visit, ask specifically about:

• Numbness or tingling in hands or feet (possible high-dose B6 neuropathy)
• Visual changes (possible SERM side effect)
• Changes in mood or sleep (both enclomiphene and B6 can affect neurotransmitter tone)

A serum pyridoxal-5-phosphate level can confirm B6 status if neuropathy symptoms emerge; normal range is 20 to 125 nmol/L. [4] Levels above 200 nmol/L with symptoms should prompt dose reduction.

Drug Interactions Beyond B6

Enclomiphene metabolism can be altered by strong CYP3A4 inhibitors and inducers. The FDA drug interaction guidance for clomiphene-class compounds recommends caution with azole antifungals, macrolide antibiotics, and rifampin. [11] These interactions are far more clinically significant than any B6 consideration and should be reviewed with the prescribing provider before starting enclomiphene.

What the Published Literature and Guidelines Actually Say

No head-to-head trial has studied enclomiphene plus vitamin B6 co-administration. The relevant evidence base draws from three separate bodies of literature.

Evidence on Enclomiphene Efficacy

A Phase III randomized controlled trial by Kim et al. (2013) published in BJU International enrolled 124 men with secondary hypogonadism and found that enclomiphene 25 mg/day raised morning testosterone from a mean of 217 ng/dL to 416 ng/dL at 3 months while preserving sperm parameters, compared with a testosterone decline in the testosterone gel arm. [12] This trial established the hormonal efficacy basis for off-label prescribing.

A further trial by Wiehle et al. (2014) in the International Journal of Andrology (N=163) found that 12.5 mg and 25 mg enclomiphene daily both significantly raised LH and testosterone at 3 months, with the 25 mg dose producing a mean serum testosterone of 450 ng/dL vs. 216 ng/dL at baseline (P<0.001). [13]

Evidence on B6 Safety Thresholds

The European Food Safety Authority (EFSA) reviewed B6 toxicity in 2023 and concluded that a tolerable upper intake level of 12.5 mg/day is appropriate for chronic supplemental use in the general EU population, a threshold far more conservative than the US NIH UL of 100 mg/day. [14] The EFSA review cited case reports of neuropathy at doses as low as 24 mg/day over prolonged periods in susceptible individuals. This European guidance creates clinical uncertainty about the 10 to 100 mg/day tier and is worth discussing with patients who plan long-term supplementation.

The Endocrine Society's 2018 guideline states: "In men with secondary hypogonadism who wish to maintain fertility, treatment with clomiphene citrate or FSH can raise serum testosterone while preserving sperm production." [1] That guidance does not address supplement co-administration, leaving the clinical decision to prescriber judgment informed by the pharmacology reviewed here.

Absence of Evidence Is Not Evidence of Safety

No published interaction study does not mean no interaction exists. It means the question has not been formally tested. Standard pharmacological reasoning based on metabolic pathways suggests the combination is low-risk at normal doses, but that reasoning has limits. Men taking enclomiphene off-label via compounding pharmacies often receive less monitoring than patients in clinical trials. That reduced oversight makes conservative B6 dosing (below 100 mg/day) a reasonable default.

Practical Clinical Instructions for Patients and Prescribers

If you are currently taking enclomiphene citrate and want to add vitamin B6, or are already taking both, these steps reflect the best available evidence.

For Patients

Check the dose on your B6 label. If it is 100 mg or below, no dose adjustment or separation window is required. Take both at whatever time suits your routine. If your B6 supplement exceeds 100 mg per tablet, discuss the dose with your prescribing physician before continuing. Report any new numbness, tingling, or balance problems at your next visit regardless of which supplement you believe caused them.

Do not take megadose B6 (500 mg or higher) during enclomiphene therapy. There is no documented clinical benefit from doses that high in this context, and the neuropathy risk is real.

For Prescribers

Review the full supplement list at every enclomiphene follow-up visit. Men self-prescribing off-label SERMs through compounding pharmacies often add multiple supplements simultaneously. B6 above 200 mg/day from all sources combined warrants counseling. If a patient on enclomiphene reports new sensory symptoms, check a serum PLP level and review the cumulative B6 intake from all supplement products (B-complex, multivitamin, standalone B6, and protein powders with added vitamins). A serum PLP above 200 nmol/L with sensory symptoms is an indication to taper B6 before attributing symptoms to SERM therapy. [4]